Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

0001411690

Bionano develops and offers optical genome mapping (OGM) solutions. Their Stratys™ and Saphyr™ systems, along with VIA™ software, enable the discovery of structural variants in the genome. Bionano positions itself as an innovator in genomics, focusing on improving health through advanced technology.

87
Très Fiable
Score de Confiance

Registre Officiel

Dénomination Sociale
Bionano Genomics, Inc.
Numéro d'organisation
0001411690
Numéro de TVA
261756290
Statut de l'Entreprise
Active
Adresse
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121
Codes d'Activité
3826: Laboratory Analytical Instruments

Dernière vérification: 1/2/2026

Analyse Qualité IA

Industrie
Biotechnology
SSL/HTTPS
Sécurisé
E-mail professionnel
Oui
E-mail de contact
support@bionano.com

Détails du Score de Confiance

Registre Vérifié35/35
Score de Qualité52/60
Sentiment de l'Actualité0/5

Liens Rapides

Dernière mise à jour: 1/2/2026

🌟 Entreprises similaires de confiance

Context Therapeutics Inc.

Context Therapeutics Inc. logo
86/100 · Très Fiable

Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.

2001 MARKET STREET, États-Unis
Voir le profil

AGENUS INC

AGENUS INC logo
86/100 · Très Fiable

Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.

3 FORBES ROAD, États-Unis
Voir le profil

Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc. logo
65/100 · Moyennement Fiable

Sigyn Therapeutics develops dialysis-like therapies for cardiovascular disease and cancer. Their therapies are designed to improve patient quality of life. Key products include CardioDialysis™ for cardiovascular disease, and ImmunePrep™, ChemoPrep™ and ChemoPure™ for cancer therapy.

9190 W OLYMPIC BLVD # 263, États-Unis
Voir le profil